Travel Health Evidence

Praktiline

Reisimine tsöliaakia või toiduallergiaga

Keelebarjäär muudab kontrolli all oleva haigusseisundi hasartmänguks. Lahendus on peamiselt logistiline ja tasub see ära teha enne reisile minekut.

Updated 2 min read 40 citations Evidence strength 3/5

Lennujaama väljumissaali ootealal on istmerivid ja ülalt tulev päevavalgus.
Jwh · CC BY-SA 3.0 lu · Wikimedia Commons

Mida ELi eeskirjad tagavad

Neliteist peamist allergeeni — sealhulgas gluteeni sisaldavad teraviljad — tuleb ELis deklareerida nii pakendatud toidus kui ka toitlustuses. Eeskirjad on piisavalt ühtsed, et tsöliaakiaga reisija seisab liikmesriikide vahel liikudes silmitsi sama märgistusraamistikuga, mis on märkimisväärne, kuid alahinnatud eelis.

Erineb see, kui hästi eeskirju täidetakse, kuidas toitlustusasutused infot avaldavad (suuliselt, menüüs, kaustas) ja kuivõrd on haigusseisund kultuuriliselt tuttav. Mõnes riigis on avalikkuse teadlikkus tsöliaakiast kõrge, teistes käsitletakse seda kui pelgalt toitumiseelistust.

Praktiline süsteem

  1. Hangi tõlkekaart kohalikus keeles, mis kirjeldab haigusseisundit meditsiiniliselt, nimetab, mida tuleb vältida, ja mainib ühiseid praepanne ning pindu. Kaart jõuab kööki; suuline lause ei jõua.
  2. Õpi lugema koostisosade loetelu, mitte keelt. Allergeenid on kogu ELis kirjastiililiselt esile tõstetud, nii et leiad need ülejäänud teksti lugemata.
  3. Broneeri majutus, kus on külmik ja veekeetja. See muudab keerulise reisi tavaliseks.
  4. Võta reisipäevadeks kaasa ohutut toitu. Just lennujaamades, jaamades ja pikkadel sõitudel jäädakse hätta.
  5. Leia kohalik tsöliaakia- või allergiaühing. Enamikus Euroopa riikides on selline olemas, mitmed avaldavad ka söögikohtade nimekirju.
  6. Võta kaasa piisavalt ravimeid — sealhulgas vajaduse korral adrenaliini autoinjektorid — ja retseptikirja.

Kindlustus ja dokumendid

Kontrolli, et reisikindlustus katab sinu haigusseisundi, ja hoia ravimeid originaalpakendis koos retseptikirjaga. ELi piires katab Euroopa ravikindlustuskaart vajaliku riikliku raviteenuse, kuid see ei ole sama mis reisikindlustus ega asenda seda.

Korduma kippuvad küsimused

Kas tõlkekaardid on tegelikult kasulikud?
Jah, rohkem kui räägitud sõnad. Kaardi saab anda kööki, kus otsused tegelikult tehakse.
Millistes Euroopa riikides on tsöliaakiaga kõige lihtsam?
Teadlikkus erineb rohkem kui regulatsioon. Rahvuslikud tsöliaakiaühingud on parim allikas, mitte üldistused.
Kas võin ravimeid piiri üle viia?
Üldiselt jah, originaalpakendis koos retseptikirjaga. Kontrollitavate ainete puhul kontrolli eraldi.
Mis siis, kui saan välismaal kogemata gluteeni?
Leevenda sümptomeid ja joo piisavalt vedelikku. Kokkupuute vastu ravi ei ole — vaata meie tsöliaakia lehekülge.
Kitsakerelise reisilennuki salongi sisevaade koos pealmiste pagasilaekate ja kolmese istmerea paigutusega.
Aykleinman (talk) · Public domain · Wikimedia Commons

Seotud lugemine

Selle lehe aluseks olevad tõendid Virnastatud tulpdiagramm, mis näitab sellel leheküljel viidatud 34 publikatsiooni jaotust uuringutüübi kaupa. 111058meta-analysis (11)randomised trial (10)review (5)other (8)
34 publikatsiooni, 1987–2026. See on segu, kus on nii uuringuid kui ka koondülevaateid, ja sellisest lähtepunktist on põhjuslikkuse kohta väite esitamine põhjendatud. Allikas: selle lehe oma viidete loetelu allpool.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Risk of anaphylaxis on commercial flights Turner PJ · Current opinion in allergy and clinical immunology · 2025 · Systematic review DOIPubMed 40643054Full text
  5. How Common Are Allergic Reactions During Commercial Flights? A Systematic Review and Meta-Analysis Turner PJ, Mamula J, Laktabi J, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Meta-analysis DOIPubMed 37507067
  6. Skin care interventions in infants for preventing eczema and food allergy Kelleher MM, Cro S, Cornelius V, et al. · The Cochrane database of systematic reviews · 2021 · Meta-analysis DOIPubMed 33545739Full text
  7. Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children Perez Chacon G, Ramsay J, Brennan-Jones CG, et al. · The Cochrane database of systematic reviews · 2021 · Systematic review DOIPubMed 34693993Full text
  8. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  9. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement Vultaggio A, Agache I, Akdis CA, et al. · Allergy · 2020 · Clinical guideline DOIPubMed 32500526Full text
  10. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  11. Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review Versluis A, Knulst AC, Kruizinga AG, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015 · Systematic review DOIPubMed 24766413
  12. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community Muraro A, Agache I, Clark A, et al. · Allergy · 2014 · Clinical guideline DOIPubMed 24905609
  13. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  14. Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies Chinthrajah RS, Kulis M, Jones SM, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41238005Full text
  15. PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort Denlinger LC, Israel E, Moore WC, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 41707916Full text
  16. Early-life peanut oral immunotherapy associated with long-term ingestion and immunologic changes Dantzer JA, Virkud YV, Cox AL, et al. · The Journal of allergy and clinical immunology · 2026 · Randomised controlled trial DOIPubMed 42167657Full text
  17. Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial Morgan WJ, Mauger DT, Bacharier LB, et al. · Lancet (London, England) · 2026 · Randomised controlled trial DOIPubMed 42705251
  18. Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial Palmer DJ, Cuthbert AR, Sullivan TR, et al. · The Journal of allergy and clinical immunology · 2025 · Randomised controlled trial DOIPubMed 39173718
  19. A pediatric randomized, controlled trial of German cockroach subcutaneous immunotherapy Zoratti E, Wood R, Pomés A, et al. · The Journal of allergy and clinical immunology · 2024 · Randomised controlled trial DOIPubMed 38718950Full text
  20. Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy Wang J, Wood RA, Raymond S, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Randomised controlled trial DOIPubMed 37087097Full text
  21. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial Kliewer KL, Gonsalves N, Dellon ES, et al. · The lancet. Gastroenterology & hepatology · 2023 · Randomised controlled trial DOIPubMed 36863390Full text
  22. Impact of an Intervention on Healthy Offerings and Allergenic Food Management in Restaurants: A Parallel Randomized Controlled Study Tarro L, Mandracchia F, Queral J, et al. · Nutrients · 2023 · Randomised controlled trial DOIPubMed 38068728Full text
  23. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial Jackson DJ, Bacharier LB, Gergen PJ, et al. · Lancet (London, England) · 2022 · Randomised controlled trial DOIPubMed 35964610Full text
  24. Randomized, double-blind, placebo-controlled, food allergy challenge to olestra snacks Burks AW, Christie L, Althage KA, et al. · Regulatory toxicology and pharmacology : RTP · 2001 · Randomised controlled trial DOIPubMed 11603960
  25. Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Pascal M, Chauhan J, Knol E, et al. · Allergy · 2025 · Review DOIPubMed 40503572Full text
  26. The epithelial barrier theory and its associated diseases Sun N, Ogulur I, Mitamura Y, et al. · Allergy · 2024 · Review DOIPubMed 39370939Full text
  27. Scope and applicability of social-ecological resilience to antimicrobial resistance Wernli D, Søgaard Jørgensen P, Parmley EJ, et al. · The Lancet. Planetary health · 2023 · Review DOIPubMed 37438004
  28. Safe Living Following Solid Organ Transplantation Blair BM · The Surgical clinics of North America · 2019 · Review DOIPubMed 30471739
  29. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  30. IgE in the diagnosis and treatment of allergic disease Platts-Mills TAE, Schuyler AJ, Erwin EA, et al. · The Journal of allergy and clinical immunology · 2016 · Review DOIPubMed 27264001Full text
  31. The restaurant syndromes Settipane GA · New England and regional allergy proceedings · 1987 · Review DOIPubMed 3302666
  32. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 The Lancet. Infectious diseases · 2026 · Journal article DOIPubMed 41412141
  33. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021 Rautalin I, Volovici V, Stark BA, et al. · JAMA neurology · 2025 · Journal article DOIPubMed 40406922Full text
  34. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  35. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  36. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092928Full text
  37. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
  38. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study Ozonoff A, Jayavelu ND, Liu S, et al. · Nature communications · 2024 · Journal article DOIPubMed 38172101Full text
  39. Formononetin inhibits IgE by huPlasma/PBMCs and mast cells/basophil activation via JAK/STAT/PI3-Akt pathways Musa I, Wang ZZ, Yang N, et al. · Frontiers in immunology · 2024 · Journal article DOIPubMed 39221239Full text
  40. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 Shin YH, Hwang J, Kwon R, et al. · Allergy · 2023 · Journal article DOIPubMed 37431853Full text

This page was translated automatically from English. The citations and numbers are unchanged. Read the English original if anything reads oddly. Read the English original